Get the Stockscreener App
3.88
0.00%
0.00
After Hours:
3.91
0.03
+0.77%
Shuttle Pharmaceuticals Holdings Inc stock is traded at $3.88, with a volume of 77,895.
It is up +0.00% in the last 24 hours and up +2.11% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$3.88
Open:
$3.78
24h Volume:
77,895
Relative Volume:
0.29
Market Cap:
$4.07M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-8.4348
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-17.45%
1M Performance:
+2.11%
6M Performance:
-84.18%
1Y Performance:
-67.67%
1-Day Range:
$3.77
$4.14
1-Week Range:
$3.54
$4.48
52-Week Range:
$3.00
$82.50
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
3.88 | 2.17M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
What analysts say about Shuttle Pharmaceuticals Holdings Inc. stockMassive stock growth - jammulinksnews.com
What drives Shuttle Pharmaceuticals Holdings Inc. stock priceFree Consultation - jammulinksnews.com
Shuttle Pharmaceuticals Holdings Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - jammulinksnews.com
Is Shuttle Pharmaceuticals Holdings Inc. a good long term investmentExceptional profit velocity - Autocar Professional
Shuttle Pharmaceuticals Plunges 11.7% on Market Concerns - AInvest
How Shuttle Pharmaceuticals Holdings Inc. stock performs during market volatilityQuick Profit Idea Stream - Newser
Why Shuttle Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionGroup Only Stock Signals - Newser
What makes Shuttle Pharmaceuticals Holdings Inc. stock price move sharplyProfessional Stock Screener - Newser
Shuttle Pharmaceuticals Secures $4.25M in Private Placement - MSN
Shuttle Pharma Announces $4.25M Private Placement Priced At-the-Market. - AInvest
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations By Stocktwits - Investing.com India
Shuttle Pharmaceuticals (NASDAQ:SHPH) Shares Up 4.3% – What’s Next? - Defense World
Shuttle Pharmaceuticals says reverse stock split to become effective June 16 - Yahoo Finance
# Shuttle Pharmaceuticals plans 25-for-1 reverse stock split By Investing.com - Investing.com South Africa
Shuttle Pharma Announces Reverse Stock Split Will Become Effective On June 16 - MarketScreener
Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time - GlobeNewswire
Shuttle Pharma Announces Major 25:1 Reverse Split: Key Details Every Investor Must Know Before June 16 - Stock Titan
# Shuttle Pharmaceuticals plans 25-for-1 reverse stock split - Investing.com
Shuttle Pharmaceuticals Holdings, Inc. Proposes 25-for-1 Reverse Stock Split to Comply with Nasdaq Requirements - Nasdaq
Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative - GlobeNewswire
Shuttle Pharma Board Approves Major 25:1 Reverse Split to Maintain Nasdaq Listing - Stock Titan
SHPH’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
Pre-market Movers: SHPH, WORX, IOVA, PLRZ... - RTTNews
Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors - GlobeNewswire
Shuttle Pharma appoints new Chairman to its Board By Investing.com - Investing.com India
Shuttle Pharma appoints new Chairman to its Board - Investing.com Australia
Shuttle Pharma Appoints George Scorsis Chairman Of The Board Of Directors - marketscreener.com
Cancer Treatment Pioneer Shuttle Pharma Taps 25-Year Industry Leader George Scorsis to Drive Growth Strategy - Stock Titan
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Increase in Short Interest - Defense World
Savara Inc (NASDAQ:SVRA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Johnson Matthey (LON:JMAT) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
Invesco WilderHill Clean Energy ETF (NYSEARCA:PBW) Shares Sold by Bank of America Corp DE - Defense World
Shuttle Pharmaceuticals slashes exec salaries by 70% as it fights to preserve cash - The Business Journals
Shuttle Pharmaceuticals Holdings Implements 70% Salary Reduction For ExecutivesSEC Filing - marketscreener.com
Shuttle Pharmaceuticals Announces Major Salary Reductions - TipRanks
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):